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TRANSPLANTABLE MURINE NATURAL KILLER CELL 
PROGENITORS: IDENTIFICATION AND ENRICHMENT. 
Moore TA*. Bennelt M. Kumar V*. U.T. Southwestern 
Medical Center, Dallas, Texas, U.S.A.
Little is understood about the earliest stages of natural 
killer (NK) cell differentiation in bone marrow or the 
lineage relationship of immature NK cells to other, more 
well defined lineages of the hematopoietic system.
By sensitivity to antibody + C' depletion, we have 
previously identified a transplantable NK progenitor
population to be heat stable antigen (HSA)+ NK1.1" 3A4- . 
To measure NK progenitors, recipient mice are treated 
with anti-NK1.1 mAb to deplele endogenous mature NK 
cells, lethally irradiated, then injected with syngeneic bone 
marrow cells. Ten to 14 days later, regeneration of mature 
NK cell function is assessed by measuring the clearance 
of injected radiolabelled YAC-1 tumor targets from the 
lungs.
Using well documented flow cytometric procedures, we 
have enriched this progenitor from within the blast size 
population of bone marrow and with the surface 
phenotype Ly-6 (Sca-1)+ Lin (B220, Gr~1, CD2, CD3, 
NK1.1)-, This population comprises approximately 0.5-
1.0% of total bmc.
Since this population is also greatly enriched for 
pluripotent stem cells as well as other hematopoietic 
lineage progenitor cells, we are currently attempting to 
further subdivide this population in order to identify a cell 
phenotype capable of generating exclusively NK cells 
upon in vivo transfer. Antigens to be examined include 
HSA, Fall-3, and CZ-1.
Finally, since NK progenitors are unresponsive to IL-2 
in vitro, we are also examining the cellular and/or cytokine 
interactions which drive progenitors to differentiate into !L- 
2 responsive NK precursor cells, which then generate 
mature NK cells.
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IN V IT R O  E V I D E N C E S  O F  T  C E L L  C O M M I T M E N T  IN H U M A N  
HONK M A R R O W .  S ch m i t t  C*. Dalloul AH. Arock M. Deb rtf P*. 
Mossa lavi  MD. D e p a r t m e n t  of Molecular  Im m u n o - h e m a to lo g y ,  
Pit i t f-Salpetr iere Hospital ,  Paris,  France.
H u m an  th y m u s  is necessary  Tor normal d ev e lo p m en t  of T coll 
c o m p a r tm en t .  However,  the  quest ion r e m a in s  to w h e th e r  T cell 
com m itm en t  occurs intrnthymicolly,  or thnL p ro thym ocytes  a re  y e t  
developed in the  bone marrow, To approach th is  ques t ion ,  we have  
analysed  phenotypic  and functional capacit ies of thymic  a n d  bone
m ar row  C D 2 ’ p recu rso rs  by tak ing  ad v en tag e  of CD7 a n d  01)34
expression.  T h r e e  subse ts  were analysis: C D 7 '3 4 +, C D 7 +34 + and  
CD7+34*. O ur  d a ta  show th a t  in the bone m ar row  CD7'34 + cells were 
not  able to form T cell colonies in a prothymocyte-specif ic  a s s a y
while CD7+34 + cells contain 1/35-53 prothymocyles. By contrast to
both subsets ,  C D 7+34' cells were not able to genera te  myeloid colonics 
(< 1/100) b u t  had  high T cell d i f fe ren t ia t ion  p o te n t i a l  (1/2-6). 
I n t r a th y m ic n l ly ,  C D 7 f is expressed by ear ly  T cell c o m p a r t m e n t  
(subcortex) while CD34 expression is a b se n t  or very  m a r g in a l  in
this t issue.  Thymocytes  ana lys is  shows th a t  CD7 + 2~3*4*8' (pro T) 
const i tute  0.2-0.4% of total thymocyles while C D 7+34+ and  Cl)7' , 'M+ 
cells a re  very  r a r e  in the  th y m u s  (>.01%).  As m a r ro w  d e r iv ed  
counte rpar t ,  ear ly  CI)7+2' thymocytes show proT coll f requencies  of 
1/3-6 while myeloid clones did not surpass  1/100. Therefore ,  thym ic
C D 7 + cells a r c  gene ra l ly  commit ted  to T  cell l ineage  with r a r e  
exception. In the  bone marrow, CD7 proLhymocytes a re  p re s e n t  and  
seems to be der ived  from more im m a tu re  OD34 + 7 + p r e c u r s o r s
possess ing  both  myeloid and lymphoid po ten t ia l ,  As C D 7 + C D 2 '
C D 34* colls were previously detected in the  u p p e r  tho rax  region of 
hum an  fetus j u s t  before thym us  genesis. Wo the re fo re  sugges t  t h a t  
c o m m i t m e n t  to T cell l ineage  a l ready  occurs  in h u m a n  bona  
m a r r o w .
RECOVERY OF MURINE LYMPHOPOIESIS FOLLOW­
ING IN VIVO ABLATION WITH ANTI-L3T4 ANTIBODY
KuKuruqa M’. Schedinq S', Media JE‘. Nakeff, A. 
Division of Hematology and Oncology, Wayne State 
University, School of Medicine, Detroit, Ml, USA
We have utilized multivariate flow cytometry to 
investigate the recovery of spleen lymphocytes following 
the in vivo depletion of the L3T4 (murine equivalent to 
human CD4) subset in mice injected with anti-L3T4 
ascites. BDF1 mice received a single i.p, injection of 0,2 
ml GK1.5 (anti-L3T4) ascites. L3T4 subsets were ablat­
ed from about 30% of total spleen cells to undetectect- 
able levels within 3 hrs and remained so for 2 weeks. 
Since L3T4 cells comprise -70%  of all T-cells, we were 
surprised to observe that the latter did not differ in 
number from control values at 3 hrs and at no later time 
did they decrease more than 15%. No changes in 
splenic weight, cellularity or the LYT2 subset were 
detected that could account for the discrepancy between 
total THY1.2 cells and the corresponding T-cell subsets, 
nor were any changes noted in the number of IgG, 
ASIALO-GM1, and MAC-1 cells . By the third week 
following the initial depletion, L3T4 cells had recovered 
to 10% of total spleen cells and over the next two weeks 
increased slowly to about 20%, LYT2 cells were elevat­
ed at 4 and 5 weeks post ablation such that the LYT2 
plus L3T4 subsets added up to the number of THY1.2 
cells. Our results indicate that a considerable fraction of 
splenic T-cells are detected within the first two weeks 
following in vivo ablation of the L3T4 subset that re­
mains undetected by monoclonal markers for L3T4 and 
LYT2.
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A C T IV A T IO N  M A R K E R  E X P R E S S IO N  O K  Till-: 
P E R I P H E R A L  B L O O D  L Y M P H O C Y T E S  O F  N O R M A L  
V O L U N T E E R S , R E C IP IE N T S  O F  IN T E R L E U K IN  2 AND 
P A T I E N T S  U N D E R G O I N G  B O N E  M A R R O W  
T R A N S P L A N T A T IO N .
A Ikinciog u lla r i , P O blakow sk i r-M D_LIa»m)u^ G G alatowic?.. 
AV Ilofihrand , CO F ig ^ o r1, nnd HG-JVentir.e. D ep a r tm en t of
H aem atology, Royal Free I lospiLai School of Medicine, 
London. UK and 'N a tio n a l C ancer In s ti tu te , 1066 CX 
A m sterdam , The N e th e rlan d s .
Dual colour im m unophe no typing  and  cytotoxicity assays on 
the p e r ip h e ra l blood lym phocytes (PBL) of norm al vo lunteers 
a f te r  c u ltu re  with or w ithou t In te r leu k in  2 (fL2) 
d em o n s tra ted  th a t  th e  in  vitro  induction  of cytotoxicity for a 
n a tu ra l  k ille r  (NK) r e s is ta n t  cell line w as accom panied by an 
increase in the  n u m b e r  of cells positive for the an tigen  bound 
by the  monoclonal an tibody  N K l-L lfi {17 ± 8% u n s tim u la lcd , 
45 ± 18% 1L2 s t im u la ted , (m ean ± s ta n d a rd  deviation), 
p<0.008) an d  an  increase  in CD71 ( tran s fe rr in  receptor) 
expression (2 ± 1.(5% u n s tim u la tcd , 12 ± 9% IL2 s tim ula ted , 
p=0.04). PBL from p a t ie n ts  who have  undergone  bone m arrow  
tra n sp la n ta t io n  (BMT), autologous or allogeneic, also showed 
increased k illing  of th e  NK re s is ta n t  cell line (1,2 ± 0.9% pro 
BMT, 9 ± 7.2% post BMT, p -0 .004) which was accom panied 
by increased NKI-L16 b ind ing  (33,1 ± 13.8% pre, 50.3 ± 21% 
post BMT, p=0.063). Increased  NK1-L16 b inding  w as 
p red om inan tly  on CD2 posiLive, CD56 negative cells. A fter 
BMT th e re  w as no change  in K562 k illin g  (16,5 ± 15% pre, 
16,5 ± 12,4% post) n o r  in the p e rcen tag e  of cells expressing  
C D 7L PB L  from rec ip ien ts  o fIL 2  in vivo  showed significantly 
increased  k illing  of N K  sensitive  (8 ± 3.9% pre, 38.5 ± 15% 
post IL2, p=0.03) and  N K re s is ta n t  (1,9 ± 1.1% pro, 11.6 ± 5% 
post. 1L2, p=s0«001) ta rg e ts  which w as associated w ith 
increased NKI-L16 (33.5 ± 14.1% pro IL2, 60 ± 20.3% post 
IL2, p=0.08) and 01)71 b in d in g  (2.7 ± 0.8% pre  IL2, 5.2 ± 
2.6% post 1L2, p=0.15). NKI-LJG and 01)71 arc  m ark e rs  of 
lym phocyte ac tivation  in v itro , but. only NK1-L1G has been 
found to be a m a rk e r  of ac tivation  in viva.
